We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
Optimizing ICH Care By Leveraging AC Reversal, AI & Care Bundling
W. Brian Gibler, MD, FACEP, FACC, FAHA
Greg Albers, MD
Rhonda Cadena, MD, FNCS, FCCM
Stuart Connolly, MD, FRCPC
Natalie Kreitzer, MD, MS
Adrian R. Parry-Jones, FRCP, PhD
Providing Optimal Care for the Anticoagulated Patient with Intracranial Hemorrhage in the Acute Care Setting: Does the Patient Need Reversal, Repletion, or Surgery?
Implementation of the 2022 AHA/ASA Guideline for the Management of Patients with Spontaneous Intracerebral Hemorrhage—Are You Doing Enough?
ABC-ICH: Does Care Bundling Improve Outcomes for Patients with Intracranial Hemorrhage?
Emerging Data in the Management of Intracranial Hemorrhage in the Anticoagulated Patient
The Frontier of Stroke Diagnosis (RapidAI): How Can Artificial Intelligence Improve Acute Care for Ischemic and Hemorrhagic Stroke?
Real World Data and the Management of Intracranial Hemorrhages (ICH) in Anticoagulated Patients
David Seiffge, MD
Repletion or Reversal? Optimizing Specific Therapy for Direct Oral Anticoagulant (DOAC)-Related Life-Threatening Bleeding Using Real-World Experience
Case Presentation: Management of a Patient With Vitamin K Antagonist-Associated Intracranial Hemorrhage (ICH)
Repletion Management for Vitamin K Antagonist Anticoagulation
Reversal of Factor Xa Inhibitor ICH: ANNEXA-4, ANNEXA-I and Real-World Evidence
Case Presentation: Management of a Patient With Factor Xa-Associated ICH Using Specific Reversal Therapy
Specific Reversal Therapy for Factor Xa and Factor IIa Inhibitor-Associated ICH Life-Threatening Bleeding
Development of a Care Pathway Using Specific Reversal Agents for Anticoagulated Patients With ICH
Case Presentation: Management of ICH in the Anticoagulated Patient Using Specific Reversal Therapy: Importance of Timing
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education